Apollomics

(NASDAQ) APLM

Current Price$15.28

Market Cap$33.93M

Since IPO (2021)-98%

5 YearN/A

1 Year+172%

1 Month+0%

Apollomics Financials at a Glance

Market Cap

$33.93M

Revenue (TTM)

$8.70M

Net Income (TTM)

$64.80M

EPS (TTM)

$-7.57

P/E Ratio

-2.04

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$15.28

Volume

1,108.322

Open

$15.56

Price

$15.28

Volume

1,108.322

Open

$15.56

Previous Close

$15.45

Daily Range

$15.45 - $15.56

52-Week Range

$3.66 - $42.12

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$15.28

Volume

1,108.322

Open

$15.56

Previous Close

$15.45

Daily Range

$15.45 - $15.56

52-Week Range

$3.66 - $42.12

APLM News

radiologist of Oncology institute is examing MRI scans

Why Shares of Apollomics Are Up Friday

James HalleyJun 2, 2023

Why Shares of Apollomics Soared in March

James HalleyApr 6, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Apollomics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Hung Wen Chen

Website

www.apollomicsinc.com

Headquarters

Foster City, CA 94404, US

APLM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-1305%

Return on Capital

-24%

Return on Assets

-2%

Earnings Yield

-49.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$33.93M

Shares Outstanding

2.20M

Volume

1.11K

Avg. Volume

7.78K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.47M

EBITDA

$9.47M

Operating Cash Flow

$10.37M

Capital Expenditure

$0.00

Free Cash Flow

$10.37M

Cash & ST Invst.

$3.28M

Total Debt

$643.00K

Apollomics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$33.93M

N/A

Market Cap/Employee

$2.61M

N/A

Employees

N/A

Net Income

$1.60M

+107.3%

EBITDA

$3.03M

+110.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$2.63M

-92.1%

Accounts Receivable

$2.49M

+434.3%

Inventory

$0.00

N/A

Long Term Debt

$434.00K

+62.5%

Short Term Debt

$209.00K

-95.2%

Return on Assets

-1.63%

N/A

Return on Invested Capital

-24.41%

N/A

Free Cash Flow

$12.76M

+44.9%

Operating Cash Flow

$12.76M

+44.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LPTXLeap Therapeutics, Inc.

LPTXLeap Therapeutics, Inc.$0.77-3.15%

ATHAAthira Pharma, Inc.

ATHAAthira Pharma, Inc.$6.75-6.12%

BLRXBioLineRx Ltd.

BLRXBioLineRx Ltd.$3.07-0.97%

ICUSeaStar Medical Holding Corporation

ICUSeaStar Medical Holding Corporation$4.49-7.61%

LNAILunai Bioworks Inc.

LNAILunai Bioworks Inc.$0.33-0.90%

MBRXMoleculin Biotech, Inc.

MBRXMoleculin Biotech, Inc.$2.47-0.80%

GOVXGeoVax Labs, Inc.

GOVXGeoVax Labs, Inc.$1.67-5.11%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$711.23+0.02%

SOFISoFi Technologies

SOFISoFi Technologies$15.75-0.02%

Questions About APLM

What is the current price of Apollomics?

Apollomics is trading at $15.45 per share.

What is the 52-week range for Apollomics?

Over the past 52 weeks, Apollomics has traded between $3.66 and $42.12.

How much debt does Apollomics have?

As of the most recent reporting period, Apollomics reported total debt of $643,000.

How much cash does Apollomics have on hand?

Apollomics reported $3.28M in cash and cash equivalents in its most recent financial results.

What is Apollomics’s dividend yield?

Apollomics does not currently have a dividend yield.

Apollomics

Apollomics Financials at a Glance

APLM News

Why Shares of Apollomics Are Up Friday

Why Shares of Apollomics Soared in March

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Apollomics

APLM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Apollomics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About APLM

What is the current price of Apollomics?

What is the 52-week range for Apollomics?

How much debt does Apollomics have?

How much cash does Apollomics have on hand?

What is Apollomics’s dividend yield?

Premium Investing Services